{"id":22505,"date":"2024-10-13T21:20:31","date_gmt":"2024-10-13T21:20:31","guid":{"rendered":"https:\/\/allonlinebanglanewspapers.com\/news\/tvtx-investor-alert-bronstein-gewirtz-and-grossman-llc-announces-an-investigation-into-travere-therapeutics-inc-and-encourages-investors-to-contact-the-firm\/"},"modified":"2024-10-13T21:20:31","modified_gmt":"2024-10-13T21:20:31","slug":"tvtx-investor-alert-bronstein-gewirtz-and-grossman-llc-announces-an-investigation-into-travere-therapeutics-inc-and-encourages-investors-to-contact-the-firm","status":"publish","type":"post","link":"https:\/\/allonlinebanglanewspapers.com\/news\/tvtx-investor-alert-bronstein-gewirtz-and-grossman-llc-announces-an-investigation-into-travere-therapeutics-inc-and-encourages-investors-to-contact-the-firm\/","title":{"rendered":"TVTX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Travere Therapeutics, Inc. and Encourages Investors to Contact the Firm"},"content":{"rendered":"<div id=\"main-body-container\" itemprop=\"articleBody\">\n<p>NEW YORK, Oct.  13, 2024  (GLOBE NEWSWIRE) &#8212; Attorney Advertising &#8212; Bronstein, Gewirtz &amp; Grossman, LLC is investigating potential claims on behalf of purchasers of Travere Therapeutics, Inc. (\u201cTravere\u201d or \u201cthe Company\u201d) (NASDAQ: TVTX). Investors who purchased Travere securities are encouraged to obtain additional information and assist the investigation by visiting the firm\u2019s site: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=lU30Jfneppt344ccJoak0YbNhJynO78JZbuj8pEh5BUn7dQk0yWWdLuRBlO4E7hwEaS1xJqweGiyvfg5GJmisA==\" rel=\"nofollow noopener\" target=\"_blank\" title=\"bgandg.com\/TVTX\">bgandg.com\/TVTX<\/a>.<\/p>\n<p><strong>Investigation Details<\/strong><\/p>\n<p>On September 26, 2024, Travere issued a press release &#8220;announc[ing] a voluntary pause of enrollment in the Phase 3 HARMONY Study evaluating pegtibatinase for the treatment of classical homocystinuria (HCU).&#8221; Travere stated that &#8220;[t]he voluntary enrollment pause enables the Company to work to address necessary process improvements in manufacturing scale-up to support commercial scale manufacturing as well as full enrollment in the HARMONY Study&#8221; and that &#8220;[t]he voluntary enrollment pause was enacted following the Company&#8217;s determination that the desired drug substance profile was not achieved in the recent scale-up process.&#8221; Following this news, Travere&#8217;s stock price fell $1.03 per share, or 6.85%, to close at $14.01 per share on September 27, 2024.<\/p>\n<p><strong>What&#8217;s Next?<\/strong><\/p>\n<p>If you are aware of any facts relating to this investigation or purchased Travere securities, you can assist this investigation by visiting the firm\u2019s site: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=lU30Jfneppt344ccJoak0XXgTxb38nQtdvmc4kkqIC7fQCRJommK7d1sXXTo6Zpxmfud0_0PAAASMD_LfI-FFg==\" rel=\"nofollow noopener\" target=\"_blank\" title=\"bgandg.com\/TVTX\">bgandg.com\/TVTX<\/a>. You can also contact Peretz Bronstein or his client relations manager, Nathan Miller, of Bronstein, Gewirtz &amp; Grossman, LLC: 332-239-2660.<\/p>\n<p><strong>There is No Cost to You<\/strong><\/p>\n<p>We represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys\u2019 fees, usually a percentage of the total recovery, only if we are successful.<\/p>\n<p><strong>Why Bronstein, Gewirtz &amp; Grossman<\/strong><\/p>\n<p>Bronstein, Gewirtz &amp; Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide.<\/p>\n<p>Attorney advertising. Prior results do not guarantee similar outcomes.<\/p>\n<p><strong>Contact<\/strong><\/p>\n<p>Bronstein, Gewirtz &amp; Grossman, LLC<br \/>Peretz Bronstein or Nathan Miller<br \/>332-239-2660 | <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=1URKufmpXhCiRM3QrqjHhdWGtGMbJh8zHJ-z2JDkiu9OwI6PkrzNzQ3ne_bLUirhxbFmgFNDrMKycI7dilFrDQ==\" rel=\"nofollow noopener\" target=\"_blank\" title=\"info@bgandg.com\">info@bgandg.com<\/a><\/p>\n<p>\n            <\/div>\n","protected":false},"excerpt":{"rendered":"<p>NEW YORK, Oct. 13, 2024 (GLOBE NEWSWIRE) &#8212; Attorney Advertising &#8212; Bronstein, Gewirtz &amp; Grossman, LLC is investigating potential claims on behalf of purchasers of Travere Therapeutics, Inc. (\u201cTravere\u201d or \u201cthe Company\u201d) (NASDAQ: TVTX). Investors who purchased Travere securities are encouraged to obtain additional information and assist the investigation by visiting the firm\u2019s site: bgandg.com\/TVTX. [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":22506,"comment_status":"","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"fifu_image_url":"https:\/\/ml.globenewswire.com\/Resource\/Download\/a0da9a10-1592-437a-9c10-d30eeb243cb7","fifu_image_alt":"","footnotes":""},"categories":[11],"tags":[],"class_list":["post-22505","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-globenewswire"],"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/allonlinebanglanewspapers.com\/news\/wp-json\/wp\/v2\/posts\/22505","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/allonlinebanglanewspapers.com\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/allonlinebanglanewspapers.com\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/allonlinebanglanewspapers.com\/news\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/allonlinebanglanewspapers.com\/news\/wp-json\/wp\/v2\/comments?post=22505"}],"version-history":[{"count":0,"href":"https:\/\/allonlinebanglanewspapers.com\/news\/wp-json\/wp\/v2\/posts\/22505\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/allonlinebanglanewspapers.com\/news\/wp-json\/wp\/v2\/media\/22506"}],"wp:attachment":[{"href":"https:\/\/allonlinebanglanewspapers.com\/news\/wp-json\/wp\/v2\/media?parent=22505"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/allonlinebanglanewspapers.com\/news\/wp-json\/wp\/v2\/categories?post=22505"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/allonlinebanglanewspapers.com\/news\/wp-json\/wp\/v2\/tags?post=22505"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}